NCT06964659View on ClinicalTrials.gov

Chronic Intervention With Sulforaphane-Smart® in Overweight and Obese Adults

EARLY_PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 31, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

December 31, 2026

Conditions
Obesity and Overweight
Interventions
DIETARY_SUPPLEMENT

Sulforaphan-Smart® formula

Volunteers will intake a daily dose of Sulforaphan-Smart® pill for 12 weeks (84 days)

OTHER

Control (placebo) group

Volunteers will intake a daily dose of placebo pill for 12 weeks (84 days)

Trial Locations (1)

30100

Edificio Pleyades-Vitalys 5ª y 6ª planta, Campus Universitario, Espinardo, Murcia

All Listed Sponsors
collaborator

Ingredalia Company

UNKNOWN

collaborator

Spanish National Research Council (CEBAS-CSIC)

UNKNOWN

lead

Mª Jesús Periago

OTHER